Progressive interstitial lung disease in a clinically quiescent dermatomyositis
doi.org/10.47895/amp.vi0.4693
- Author:
Jan Michael Jesse C. Lomanta
1
;
Milraam L. Quinto
1
,
2
;
Sheen C. Urquiza
3
;
Charito Cruz-Bermudez
4
;
Joel M. Santiaguel
1
,
5
Author Information
1. Division of Pulmonary Medicine, Philippine General Hospital, University of the Philippines Manila
2. Department of Medicine, St. Lukes Medical Center, Bonifacio Global City
3. Department of Radiology, Philippine General Hospital, University of the Philippines Manila
4. Rheumatology, Allergology and Immunology Center, St. Lukes Medical Center, Quezon City
5. Department of Medicine, Quirino Memorial Medical Center, Quezon City
- Publication Type:Case Reports
- MeSH:
dermatomyositis;
interstitial lung disease;
immunomodulator
- From:
Acta Medica Philippina
2023;57(4):68-72
- CountryPhilippines
- Language:English
-
Abstract:
A 60-year-old Filipino woman diagnosed with dermatomyositis was initially on prednisone and methotrexate. She eventually developed interstitial lung disease (ILD) and so methotrexate was shifted to azathioprine; however, azathioprine was discontinued due to cutaneous tuberculosis. Over eight years, the dermatomyositis was controlled by prednisone alone but the ILD worsened. This case demonstrated that the course of ILD may be independent of dermatomyositis.
- Full text:Progressive Interstitial Lung Disease in a Clinically Quiescent Dermatomyositis.pdf
